{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:43:23Z","timestamp":1790909003378,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10474-7","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:28:36Z","timestamp":1744194516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Repurposing serotonergic drugs for gastric cancer: induction of apoptosis in vitro"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-1070","authenticated-orcid":false,"given":"Fatemeh","family":"Abedini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1328-6285","authenticated-orcid":false,"given":"Omolbanin","family":"Amjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-4050","authenticated-orcid":false,"given":"Ghasem","family":"Ahangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"10474_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2018) Global cancer observatory: cancer today. Lyon, France: international agency for research on cancer. 3, 2019"},{"key":"10474_CR2","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1038\/s41467-022-33282-0","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Xu C, Wang B, Xu F, Ma F, Qu Y, Jiang D, Li K, Feng J, Tian S, Wu X, Wang Y, Liu Y, Qin Z, Liu Y, Qin J, Song Q, Zhang X, Sujie A, Huang J, Liu T, Shen K, Zhao J-Y, Hou Y, Ding C (2022) Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies. Nat Commun 13:5723. https:\/\/doi.org\/10.1038\/s41467-022-33282-0","journal-title":"Nat Commun"},{"key":"10474_CR3","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1038\/s41598-024-56431-5","volume":"14","author":"C Zhu","year":"2024","unstructured":"Zhu C, Lu Y, Wang S, Song J, Ding Y, Wang Y, Dong C, Liu J, Qiu W, Qi W (2024) Nortriptyline hydrochloride, a potential candidate for drug repurposing, inhibits gastric cancer by inducing oxidative stress by triggering the Keap1-Nrf2 pathway. Sci Rep 14:6050. https:\/\/doi.org\/10.1038\/s41598-024-56431-5","journal-title":"Sci Rep"},{"key":"10474_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W-L (2024) Drug repurposing for cancer therapy. Signal Transduct Target Therapy 9:92. https:\/\/doi.org\/10.1038\/s41392-024-01808-1","journal-title":"Signal Transduct Target Therapy"},{"key":"10474_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14737140.2022.1987221","volume":"22","author":"GD Lianos","year":"2022","unstructured":"Lianos GD, Alexiou GA, Rausei S, Galani V, Mitsis M, Kyritsis AP (2022) Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives. Expert Rev Anticancer Ther 22:131\u2013134. https:\/\/doi.org\/10.1080\/14737140.2022.1987221","journal-title":"Expert Rev Anticancer Ther"},{"key":"10474_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7150\/jca.34847","volume":"11","author":"C Dai","year":"2020","unstructured":"Dai C, Liu P, Wang X, Yin Y, Jin W, Shen L, Chen Y, Chen Z, Wang Y (2020) The antipsychotic agent Sertindole exhibited antiproliferative activities by inhibiting the STAT3 signaling pathway in human gastric cancer cells. J Cancer 11:849\u2013857. https:\/\/doi.org\/10.7150\/jca.34847","journal-title":"J Cancer"},{"key":"10474_CR7","doi-asserted-by":"publisher","unstructured":"Guzel T, Mirowska-Guzel D (2022) The role of serotonin neurotransmission in Gastrointestinal tract and pharmacotherapy. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27051680","DOI":"10.3390\/molecules27051680"},{"key":"10474_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbrc.2022.06.088","volume":"620","author":"X Jin","year":"2022","unstructured":"Jin X, Li H, Li B, Zhang C, He Y (2022) Knockdown and Inhibition of hydroxytryptamine receptor 1D suppress proliferation and migration of gastric cancer cells. Biochem Biophys Res Commun 620:143\u2013149. https:\/\/doi.org\/10.1016\/j.bbrc.2022.06.088","journal-title":"Biochem Biophys Res Commun"},{"key":"10474_CR9","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.7150\/thno.55986","volume":"11","author":"S Karmakar","year":"2021","unstructured":"Karmakar S, Lal G (2021) Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics 11:5296\u20135312. https:\/\/doi.org\/10.7150\/thno.55986","journal-title":"Theranostics"},{"key":"10474_CR10","doi-asserted-by":"publisher","unstructured":"Balakrishna P, George S, Hatoum H, Mukherjee S (2021) Serotonin pathway in cancer. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22031268","DOI":"10.3390\/ijms22031268"},{"key":"10474_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3892\/etm.2019.8308","volume":"19","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Wang W, Wu X, Shi J (2020) Pizotifen inhibits the proliferation and invasion of gastric cancer cells. Exp Ther Med 19:817\u2013824. https:\/\/doi.org\/10.3892\/etm.2019.8308","journal-title":"Exp Ther Med"},{"key":"10474_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000530878","volume":"101","author":"F Abedini","year":"2023","unstructured":"Abedini F, Amjadi O, Hedayatizadeh-Omran A, Lira SA, Ahangari G (2023) Serotonin receptors and acetylcholinesterase gene expression alternations: the potential value on tumor microenvironment of gastric cancer. Oncology 101:415\u2013424. https:\/\/doi.org\/10.1159\/000530878","journal-title":"Oncology"},{"key":"10474_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2739\/kurumemedj.58.73","volume":"58","author":"A Koga","year":"2011","unstructured":"Koga A, Aoyagi K, Imaizumi T, Miyagi M, Shirouzu K (2011) Comparison between the gastric cancer cell line MKN-45 and the high-potential peritoneal dissemination gastric cancer cell line MKN-45P. Kurume Med J 58:73\u201379. https:\/\/doi.org\/10.2739\/kurumemedj.58.73","journal-title":"Kurume Med J"},{"key":"10474_CR14","doi-asserted-by":"publisher","unstructured":"Wan C, Yan X, Hu B, Zhang X (2022) Emerging roles of the nervous system in Gastrointestinal cancer development. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14153722","DOI":"10.3390\/cancers14153722"},{"key":"10474_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I (2022) Epidemiology of stomach cancer. World J Gastroenterol 28:1187\u20131203. https:\/\/doi.org\/10.3748\/wjg.v28.i12.1187","journal-title":"World J Gastroenterol"},{"key":"10474_CR16","doi-asserted-by":"publisher","first-page":"116844","DOI":"10.1016\/j.biopha.2024.116844","volume":"176","author":"Y Yang","year":"2024","unstructured":"Yang Y, Sun L, Liu X, Liu W, Zhang Z, Zhou X, Zhao X, Zheng R, Zhang Y, Guo W, Wang X, Li X, Pang J, Li F, Tao Y, Shi D, Shen W, Wang L, Zang J, Li S (2024) Neurotransmitters: impressive regulators of tumor progression. Biomed Pharmacother 176:116844. https:\/\/doi.org\/10.1016\/j.biopha.2024.116844","journal-title":"Biomed Pharmacother"},{"key":"10474_CR17","doi-asserted-by":"publisher","unstructured":"Wang K, Zhao X-h, Liu J, Zhang R, Li J-p (2020) Nervous system and gastric cancer. Biochimica et biophysica acta (BBA) - Reviews on cancer. 1873:188313. https:\/\/doi.org\/10.1016\/j.bbcan.2019.188313","DOI":"10.1016\/j.bbcan.2019.188313"},{"key":"10474_CR18","doi-asserted-by":"publisher","first-page":"e1750","DOI":"10.1002\/ctm2.1750","volume":"14","author":"L Chen","year":"2024","unstructured":"Chen L, Huang S, Wu X, He W, Song M (2024) Serotonin signalling in cancer: emerging mechanisms and therapeutic opportunities. Clin Translational Med 14:e1750. https:\/\/doi.org\/10.1002\/ctm2.1750","journal-title":"Clin Translational Med"},{"key":"10474_CR19","doi-asserted-by":"publisher","first-page":"eabc8188","DOI":"10.1126\/scitranslmed.abc8188","volume":"13","author":"MA Schneider","year":"2021","unstructured":"Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, Lehmann K, Ungeth\u00fcm U, Kobold S, Graf R, van den Broek M, Berg V, Gupta J, A., Clavien PA (2021) Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint Blockade therapy in murine tumor models. Sci Transl Med 13:eabc8188. https:\/\/doi.org\/10.1126\/scitranslmed.abc8188","journal-title":"Sci Transl Med"},{"key":"10474_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood-2012-07-443903","volume":"121","author":"L Qin","year":"2013","unstructured":"Qin L, Zhao D, Xu J, Ren X, Terwilliger EF, Parangi S, Lawler J, Dvorak HF, Zeng H (2013) The vascular permeabilizing factors Histamine and serotonin induce angiogenesis through TR3\/Nur77 and subsequently truncate it through thrombospondin-1. Blood 121:2154\u20132164. https:\/\/doi.org\/10.1182\/blood-2012-07-443903","journal-title":"Blood"},{"key":"10474_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/ppo.0000000000000369","volume":"25","author":"MK Khan","year":"2019","unstructured":"Khan MK, Nasti TH, Buchwald ZS, Weichselbaum RR, Kron SJ (2019) Repurposing drugs for cancer radiotherapy: early successes and emerging opportunities. Cancer J 25:106\u2013115. https:\/\/doi.org\/10.1097\/ppo.0000000000000369","journal-title":"Cancer J"},{"key":"10474_CR22","doi-asserted-by":"publisher","unstructured":"Ara\u00fajo D, Ribeiro E, Amorim I, Vale N (2022) Repurposed drugs in gastric cancer. Molecules 28. https:\/\/doi.org\/10.3390\/molecules28010319","DOI":"10.3390\/molecules28010319"},{"key":"10474_CR23","doi-asserted-by":"publisher","unstructured":"Irving H, Turek I, Kettle C, Yaakob N (2021) Tapping into 5-HT(3) receptors to modify metabolic and immune responses. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222111910","DOI":"10.3390\/ijms222111910"},{"key":"10474_CR24","doi-asserted-by":"publisher","unstructured":"Lee JS, Park SY, Kim NY, Kim DW, Oh JE, Heo E, Lee JS, Yoo YC (2019) Anti-Tumor potential of a 5-HT3 receptor antagonist as a novel autophagy inducer in lung cancer: A retrospective clinical study with in vitro confirmation. J Clin Med 8. https:\/\/doi.org\/10.3390\/jcm8091380","DOI":"10.3390\/jcm8091380"},{"key":"10474_CR25","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1111\/cas.14592","volume":"111","author":"M Tone","year":"2020","unstructured":"Tone M, Tahara S, Nojima S, Motooka D, Okuzaki D, Morii E (2020) HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma. Cancer Sci 111:3953\u20133961. https:\/\/doi.org\/10.1111\/cas.14592","journal-title":"Cancer Sci"},{"key":"10474_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1586\/17474086.2013.827415","volume":"6","author":"O Vitagliano","year":"2013","unstructured":"Vitagliano O, Addeo R, D\u2019Angelo V, Indolfi C, Indolfi P, Casale F (2013) The Bcl-2\/Bax and Ras\/Raf\/MEK\/ERK signaling pathways: implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches. Expert Rev Hematol 6:587\u2013597. https:\/\/doi.org\/10.1586\/17474086.2013.827415","journal-title":"Expert Rev Hematol"},{"key":"10474_CR27","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.Cir-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, Chen Y, Tan Y, Hu R (2021) Overproduction of Gastrointestinal 5-HT promotes Colitis-Associated colorectal cancer progression via enhancing NLRP3 inflammasome activation. Cancer Immunol Res 9:1008\u20131023. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-1043","journal-title":"Cancer Immunol Res"},{"key":"10474_CR28","unstructured":"Razavi SR, Abedini AF, Rahimi F B and, Ahangari G (2022) A novel report of serotonin receptors antagonists inducing apoptosis in human lung carcinoma cells. Cancer Res Therap Oncol"},{"key":"10474_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2337\/db19-0546","volume":"69","author":"JH Moon","year":"2020","unstructured":"Moon JH, Kim YG, Kim K, Osonoi S, Wang S, Saunders DC, Wang J, Yang K, Kim H, Lee J, Jeong JS, Banerjee RR, Kim SK, Wu Y, Mizukami H, Powers AC, German MS, Kim H (2020) Serotonin regulates adult \u03b2-Cell mass by stimulating perinatal \u03b2-Cell proliferation. Diabetes 69:205\u2013214. https:\/\/doi.org\/10.2337\/db19-0546","journal-title":"Diabetes"},{"key":"10474_CR30","doi-asserted-by":"publisher","unstructured":"Benhassine M, Gu\u00e9rin SL (2018) Transcription of the human 5-Hydroxytryptamine receptor 2B (HTR2B) gene is under the regulatory influence of the transcription factors NFI and RUNX1 in human uveal melanoma. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19103272","DOI":"10.3390\/ijms19103272"},{"key":"10474_CR31","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1158\/0008-5472.Can-23-1012","volume":"83","author":"RH Tu","year":"2023","unstructured":"Tu RH, Wu SZ, Huang ZN, Zhong Q, Ye YH, Zheng CH, Xie JW, Wang JB, Lin JX, Chen QY, Huang CM, Lin M, Lu J, Cao LL, Li P (2023) Neurotransmitter receptor HTR2B regulates lipid metabolism to inhibit ferroptosis in gastric cancer. Cancer Res 83:3868\u20133885. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-1012","journal-title":"Cancer Res"},{"key":"10474_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11:797. https:\/\/doi.org\/10.1038\/s41419-020-02998-6","journal-title":"Cell Death Dis"},{"key":"10474_CR33","doi-asserted-by":"publisher","first-page":"117428","DOI":"10.1016\/j.biopha.2024.117428","volume":"179","author":"J-Y Lee","year":"2024","unstructured":"Lee J-Y, Park S, Park EJ, Pagire HS, Pagire SH, Choi B-W, Park M, Fang S, Ahn JH, Oh C-M (2024) Inhibition of HTR2B-mediated serotonin signaling in colorectal cancer suppresses tumor growth through ERK signaling. Biomed Pharmacother 179:117428. https:\/\/doi.org\/10.1016\/j.biopha.2024.117428","journal-title":"Biomed Pharmacother"},{"key":"10474_CR34","doi-asserted-by":"publisher","first-page":"11027","DOI":"10.1021\/acs.jmedchem.3c01178","volume":"66","author":"AM Bender","year":"2023","unstructured":"Bender AM, Parr LC, Livingston WB, Lindsley CW, Merryman WD (2023) 2B determined: the future of the serotonin receptor 2B in drug discovery. J Med Chem 66:11027\u201311039. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01178","journal-title":"J Med Chem"},{"key":"10474_CR35","doi-asserted-by":"publisher","first-page":"620212","DOI":"10.3389\/fonc.2021.620212","volume":"11","author":"YM Feng","year":"2021","unstructured":"Feng YM, Chen TH, Berman D, Chou CK, Liao KS, Hsieh MC, Chen CY (2021) Efficacy of Cyproheptadine monotherapy in hepatocellular carcinoma with bone metastasis: A case report. Front Oncol 11:620212. https:\/\/doi.org\/10.3389\/fonc.2021.620212","journal-title":"Front Oncol"},{"key":"10474_CR36","doi-asserted-by":"publisher","first-page":"105135","DOI":"10.1016\/j.tiv.2021.105135","volume":"73","author":"S Kacar","year":"2021","unstructured":"Kacar S, Hacioglu C, Kar F, Sahinturk V, Kanbak G (2021) Cyproheptadine causes apoptosis and decreases inflammation by disrupting thiol\/disulfide balance and enhancing the levels of SIRT1 in C6 glioblastoma cells. Toxicol in Vitro 73:105135. https:\/\/doi.org\/10.1016\/j.tiv.2021.105135","journal-title":"Toxicol in Vitro"},{"key":"10474_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/ejh.12193","volume":"91","author":"J Li","year":"2013","unstructured":"Li J, Cao B, Zhou S, Zhu J, Zhang Z, Hou T, Mao X (2013) Cyproheptadine-induced myeloma cell apoptosis is associated with Inhibition of the PI3K\/AKT signaling. Eur J Haematol 91:514\u2013521. https:\/\/doi.org\/10.1111\/ejh.12193","journal-title":"Eur J Haematol"},{"key":"10474_CR38","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s11033-024-10033-6","volume":"51","author":"A Shannar","year":"2024","unstructured":"Shannar A, Sarwar MS, Dave PD, Chou PJ, Peter RM, Xu J, Pan Y, Rossi F, Kong A-N (2024) Cyproheptadine inhibits in vitro and in vivo lung metastasis and drives metabolic rewiring. Mol Biol Rep 51:1139. https:\/\/doi.org\/10.1007\/s11033-024-10033-6","journal-title":"Mol Biol Rep"},{"key":"10474_CR39","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41467-020-15292-y","volume":"11","author":"P Plenge","year":"2020","unstructured":"Plenge P, Abramyan AM, S\u00f8rensen G, M\u00f8rk A, Weikop P, Gether U, Bang-Andersen B, Shi L, Loland CJ (2020) The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter. Nat Commun 11:1491. https:\/\/doi.org\/10.1038\/s41467-020-15292-y","journal-title":"Nat Commun"},{"key":"10474_CR40","doi-asserted-by":"publisher","unstructured":"He L, Fu Y, Tian Y, Wang X, Zhou X, Ding RB, Qi X, Bao J (2023) Antidepressants as autophagy modulators for cancer therapy. Molecules 28. https:\/\/doi.org\/10.3390\/molecules28227594","DOI":"10.3390\/molecules28227594"},{"key":"10474_CR41","doi-asserted-by":"publisher","first-page":"215717","DOI":"10.1016\/j.canlet.2022.215717","volume":"540","author":"S Timilsina","year":"2022","unstructured":"Timilsina S, Rajamanickam S, Rao A, Subbarayalu P, Nirzhor S, Abdelfattah N, Viswanadhapalli S, Chen Y, Jatoi I, Brenner A, Rao MK, Vadlamudi R, Kaklamani V (2022) The antidepressant Imipramine inhibits breast cancer growth by targeting Estrogen receptor signaling and DNA repair events. Cancer Lett 540:215717. https:\/\/doi.org\/10.1016\/j.canlet.2022.215717","journal-title":"Cancer Lett"},{"key":"10474_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s12192-020-01124-x","volume":"25","author":"W Gao","year":"2020","unstructured":"Gao W, Guo N, Zhao S, Chen Z, Zhang W, Yan F, Liao H, Chi K (2020) HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling. Cell Stress Chaperones 25:899\u2013908. https:\/\/doi.org\/10.1007\/s12192-020-01124-x","journal-title":"Cell Stress Chaperones"},{"key":"10474_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2014.07.054","volume":"741","author":"G Rocha Gda","year":"2014","unstructured":"Rocha Gda G, Oliveira RR, Kaplan MA, Gattass CR (2014) 3\u03b2-Acetyl tormentic acid reverts MRP1\/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and Inhibition of GST activity. Eur J Pharmacol 741:140\u2013149. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.054","journal-title":"Eur J Pharmacol"},{"key":"10474_CR44","doi-asserted-by":"publisher","first-page":"115490","DOI":"10.18632\/oncotarget.23302","volume":"8","author":"CK Then","year":"2017","unstructured":"Then CK, Liu KH, Liao MH, Chung KH, Wang JY, Shen SC (2017) Antidepressants, Sertraline and Paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes. Oncotarget 8:115490\u2013115502. https:\/\/doi.org\/10.18632\/oncotarget.23302","journal-title":"Oncotarget"},{"key":"10474_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/omi.2022.0044","volume":"26","author":"B Xue","year":"2022","unstructured":"Xue B, Chaddha M, Elasbali AM, Zhu Z, Jairajpuri DS, Alhumaydhi FA, Mohammad T, Abdulmonem WA, Sharaf SE, Hassan MI (2022) Death-Associated protein kinase 3 inhibitors identified by virtual screening for drug discovery in cancer and hypertension. Omics 26:404\u2013413. https:\/\/doi.org\/10.1089\/omi.2022.0044","journal-title":"Omics"},{"key":"10474_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41416-019-0640-1","volume":"122","author":"M Sola-Penna","year":"2020","unstructured":"Sola-Penna M, Paix\u00e3o LP, Branco JR, Ochioni AC, Albanese JM, Mundim DM, Baptista-de-Souza D, Figueiredo CP, Coelho WS, Marcondes MC, Zancan P (2020) Serotonin activates Glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1\/STAT3\/ERK1\/2 and adenylate Cyclase\/PKA, respectively. Br J Cancer 122:194\u2013208. https:\/\/doi.org\/10.1038\/s41416-019-0640-1","journal-title":"Br J Cancer"},{"key":"10474_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1570163813666151126215210","volume":"12","author":"SH Hejazi","year":"2015","unstructured":"Hejazi SH, Ahangari G, Deezagi A (2015) Alternative viewpoint against breast cancer based on selective serotonin receptors 5HTR3A and 5HTR2A antagonists that can mediate apoptosis in MCF-7 cell line. Curr Drug Discov Technol 12:240\u2013249. https:\/\/doi.org\/10.2174\/1570163813666151126215210","journal-title":"Curr Drug Discov Technol"},{"key":"10474_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2016.10.011","volume":"123","author":"S Boroda","year":"2017","unstructured":"Boroda S, Niccum M, Raje V, Purow BW, Harris TE (2017) Dual activities of ritanserin and R59022 as DGK\u03b1 inhibitors and serotonin receptor antagonists. Biochem Pharmacol 123:29\u201339. https:\/\/doi.org\/10.1016\/j.bcp.2016.10.011","journal-title":"Biochem Pharmacol"},{"key":"10474_CR49","doi-asserted-by":"publisher","first-page":"113985","DOI":"10.1016\/j.biopha.2022.113985","volume":"157","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Chang X, Huang Y, He D (2023) The application of antidepressant drugs in cancer treatment. Biomed Pharmacother 157:113985. https:\/\/doi.org\/10.1016\/j.biopha.2022.113985","journal-title":"Biomed Pharmacother"},{"key":"10474_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12032-024-02338-0","volume":"41","author":"M Salama","year":"2024","unstructured":"Salama M, Ali A, Ibrahim FAR, Elabd S (2024) Citalopram, an antipsychotic agent, induces G1\/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells. Med Oncol 41:105. https:\/\/doi.org\/10.1007\/s12032-024-02338-0","journal-title":"Med Oncol"},{"key":"10474_CR51","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/ijms23052711","volume":"23","author":"M Taler","year":"2022","unstructured":"Taler M, Gil-Ad I, Brener I, Hornfeld SH, Weizman A (2022) Complex effects of Sertraline and Citalopram on in vitro murine breast cancer proliferation and on in vivo progression and anxiety level. Int J Mol Sci 23:2711","journal-title":"Int J Mol Sci"},{"key":"10474_CR52","first-page":"1465","volume":"12","author":"BH Liu","year":"2022","unstructured":"Liu BH, Yuan TM, Huang CJ, Hsu DT, Chen SW, Hsiao NW, Lin SC, Wu SW, Lin YJ, Chuang SM (2022) DNA repair proteins as the targets for Paroxetine to induce cytotoxicity in gastric cancer cell AGS. Am J Cancer Res 12:1465\u20131483","journal-title":"Am J Cancer Res"},{"key":"10474_CR53","doi-asserted-by":"publisher","first-page":"Cd014384","DOI":"10.1002\/14651858.CD014384.pub2","volume":"11","author":"A Rodolico","year":"2022","unstructured":"Rodolico A, Siafis S, Bighelli I, Samara MT, Hansen WP, Salomone S, Aguglia E, Cutrufelli P, Bauer I, Baeckers L, Leucht S (2022) Antipsychotic dose reduction compared to dose continuation for people with schizophrenia. Cochrane Database Syst Rev 11:Cd014384. https:\/\/doi.org\/10.1002\/14651858.CD014384.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10474_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/ejh.12193","volume":"91","author":"J Li","year":"2013","unstructured":"Li J, Cao B, Zhou S, Zhu J, Zhang Z, Hou T, Mao X (2013) Cyproheptadine-induced myeloma cell apoptosis is associated with Inhibition of the PI3K\/AKT signaling. Eur J Haematol 91:514\u2013521. https:\/\/doi.org\/10.1111\/ejh.12193","journal-title":"Eur J Haematol"},{"key":"10474_CR55","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.1111\/jcmm.16874","volume":"25","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang X, Wang X, Wu D, Qi J, Zhang Y, Wang K, Zhou D, Meng Q-M, Nie E, Wang Q, Yu R-T, Zhou X-P (2021) Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with Temozolomide. J Cell Mol Med 25:9350\u20139363. https:\/\/doi.org\/10.1111\/jcmm.16874","journal-title":"J Cell Mol Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10474-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:27:40Z","timestamp":1766852860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10474-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10474"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10474-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study is research involving the MKN-45 gastric cancer cell line obtained from the Cell Bank of the Pasteur Institute of Iran (IPI).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}